You are viewing: Italy Nucleic Acid Isolation and Purification Market analysis

The Italy Nucleic Acid Isolation and Purification Market was valued at $57.09 Million in 2026 and projected to reach to $85.69 Million by 2031, representing a compound annual growth rate of 8.5%. Italy's nucleic acid isolation and purification market demonstrates consistent growth momentum, supported by the country's advanced healthcare infrastructure and expanding genomic research initiatives.

Italy Nucleic Acid Isolation and Purification Market Trends and Insights

  • Italy's healthcare sector is increasingly adopting advanced molecular diagnostics and genomic research technologies, driving demand for high-quality nucleic acid extraction solutions.
  • The country's strong pharmaceutical and biotechnology infrastructure supports market growth through investments in research facilities and clinical laboratories. The Italian market benefits from rising prevalence of genetic disorders, infectious diseases, and cancer diagnoses that require nucleic acid testing and analysis.
  • Italy's regulatory environment and healthcare spending patterns favor the adoption of automated and manual isolation systems across hospitals, diagnostic centers, and research institutions.
  • Between 2026 and 2031, Italy is expected to see accelerated adoption of next-generation sequencing and personalized medicine applications, further propelling demand for reliable isolation and purification technologies..

Key Market Statistics

  • CAGR (2026-2031) : 8.5% CAGR
  • Market Size, 2026 : ~USD 57.09
  • Forecast, 2031 : ~USD 85.69
  • Country : Italy

Italy Nucleic Acid Isolation and Purification Market Overview

Market Valuation Growth :

Italy's nucleic acid isolation and purification market is valued at $57.09 million in 2026, with a projected CAGR of 8.5% through 2031, reaching $85.69 million by forecast end.

Molecular Diagnostics Adoption :

Italian healthcare institutions are rapidly integrating advanced molecular diagnostics and genomic research technologies, creating sustained demand for high-quality nucleic acid extraction solutions across clinical and research settings.

Pharmaceutical & Biotech Sector Strength :

Italy's robust pharmaceutical and biotechnology industry serves as a key driver, with companies investing in genomic research, personalized medicine, and diagnostic development requiring premium nucleic acid purification products.

Regional Healthcare Innovation :

Italian research institutions and hospitals are modernizing their molecular biology capabilities, supporting the expansion of nucleic acid isolation technologies in both academic and clinical laboratory environments.

Italy Nucleic Acid Isolation and Purification Market Dynamics

  • The market benefits from increasing investments in molecular diagnostics, personalized medicine, and biotech innovation across Italian pharmaceutical companies and research institutions. Looking ahead to 2031, Italy's market is positioned for sustained expansion as healthcare providers prioritize precision medicine and molecular testing capabilities.
  • Growing regulatory support for advanced diagnostics, coupled with rising demand from clinical laboratories and research centers, will continue to drive adoption of sophisticated nucleic acid extraction technologies throughout the Italian healthcare ecosystem..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Italy's nucleic acid isolation market is valued at $57.09 million in 2026 and will grow to $85.69 million by 2031, representing an 8.5% CAGR.
      • Italy's strong pharmaceutical and biotechnology infrastructure drives adoption of advanced molecular diagnostics and genomic research technologies.
      • Rising prevalence of genetic disorders, infectious diseases, and cancer in Italy increases demand for nucleic acid testing and isolation solutions.
      • Italy's healthcare system is shifting toward personalized medicine and next-generation sequencing, accelerating market expansion through 2031.

      Italy Nucleic Acid Isolation and Purification Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CELL-FREE SAMPLES (Sample Type)
      Forecast Period 2026–2031
      Growth Rate CAGR of 8.7% from 2026 to 2031
      Largest Segment CELLULAR SAMPLES (Sample Type)
      Market Size Base Year 6.37 (2026)
      Revenue Forecast 9.66 (2031)
      Segments Covered Product, Type, Method, Sample Type

      Italy Nucleic Acid Isolation and Purification Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • Instruments
      • Kits
      • Reagents

      By Type

      • Automatic Instruments
      • Bacterial Cells
      • Cfdna/Ctdna
      • Circulating Nucleic Acid Isolation And Purification
      • Cultured Cells
      • Ffpe
      • Fresh/Frozen Tissues
      • Genomic Dna Isolation And Purification
      • Manual Instruments
      • Messenger Rna Isolation And Purification
      • Microrna Isolation And Purification
      • Other Cell-Free Samples
      • Other Cellular Samples
      • Other Nucleic Acid Isolation And Purification Types
      • Other Preserved Tissue Samples
      • Plasmid Dna Isolation And Purification
      • Total Rna Isolation And Purification
      • Wbcs

      By Method

      • Column-Based Isolation And Purification
      • Magnetic Bead-Based Isolation And Purification
      • Other Isolation And Purification Methods
      • Reagent-Based Isolation And Purification

      By Sample Type

      • Cell-Free Samples
      • Cellular Samples
      • Other Samples
      • Preserved Tissue Samples

      Target Audience

      • Italian Pharmaceutical Companies : Need market intelligence to guide R&D investments in genomic research and diagnostic product development, understanding local demand drivers and competitive positioning within Italy's nucleic acid market.
      • Biotech & Diagnostics Manufacturers : Require Italy-specific market data to assess expansion opportunities, optimize product portfolios for Italian clinical laboratories, and develop localized go-to-market strategies for nucleic acid isolation solutions.
      • Clinical Laboratory Directors : Need insights into market trends, technology adoption rates, and supplier landscape in Italy to make informed procurement decisions and upgrade molecular diagnostics capabilities.
      • Healthcare Investment Firms : Seek Italy-focused market analysis to evaluate investment opportunities in genomic research, molecular diagnostics, and biotech companies operating within the Italian nucleic acid isolation market.
      • Research Institution Leaders : Require market outlook data to justify funding requests, benchmark genomic research capabilities against Italian peers, and identify emerging technologies in nucleic acid purification for institutional adoption.

      Key Companies in the Italy Nucleic Acid Isolation and Purification Market

      CompanyHQOwnershipStrongest segments
      SIGMA-ALDRICH CORPORATIONUnited StatesPrivate CompanyAnalytical chemistry, labware, and materials science,Cell culture media, critical raw materials, and industrial microbiology,Molecular biology, functional genomics, and protein biology,
      BECKMAN COULTERUnited StatesPrivate CompanyClinical diagnostics (chemistry, immunoassay, hematology, urinalysis, hemostasis),Flow cytometry and cellular analysis,Life science research tools (centrifugation, genomics, liquid handling, spectrophotometry),
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (traditional and transition EPC),Urban Solutions (AT&M, life sciences, mining, infrastructure),Mission Solutions (government, nuclear remediation, security),
      SANOFIFrancePublic CompanyVaccines (pediatric, RSV, hexavalent, travel),Immunology & Inflammation,Rare Diseases & Neurology,
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (including Ultrasound and Image-Guided Therapies),Patient Care Solutions,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      QIAGEN N.V.NetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics,Oncology and sexual/reproductive health assays,
      MERCK KGAAGermanyPublic CompanyLife Science,Healthcare,Electronics,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic solutions),Diagnostics (clinical instruments, consumables, software),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research & Bioprocess,
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based products,
      TAKARA BIO INC.JapanPrivate CompanyGenetic and cellular research reagents,PCR instruments and cellular analysis devices,In vitro diagnostics (including COVID-19),
      REVVITY INC.United StatesPublic CompanyDiagnostics (prenatal, neonatal, infectious disease, immunodiagnostics),Life science reagents and assay platforms,Instruments, imaging, and detection systems,
      BIONEER CORPORATIONSouth KoreaPublic CompanyPCR / RT-PCR and real-time PCR reagents and instruments,Molecular diagnostics kits and MDx extraction systems,Research reagents, RNAi, chemicals, buffers, and consumables,

      SIGMA-ALDRICH CORPORATION

      Sigma-Aldrich Corporation is a United States-based private company founded in 1951 that employs 9,800 people. The company specializes in providing research chemicals, biochemicals, and laboratory supplies to the scientific community.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees. The company manufactures and distributes laboratory instruments and diagnostic equipment.

      FLUOR CORPORATION

      Fluor Corporation is a United States-based public company founded in 1912 with 22,995 employees. The company provides engineering, procurement, and construction services across multiple industries.

      SANOFI

      Sanofi is a France-based public company founded in 1994 with 74,846 employees. The company is a global pharmaceutical organization engaged in the research, development, and commercialization of medicines.

      GE HEALTHCARE

      GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees. The company provides medical imaging, diagnostics, and healthcare IT solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in serving science, providing laboratory equipment, reagents, and analytical instruments.

      QIAGEN N.V.

      QIAGEN N.V. is a Netherlands-based public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences research products.

      MERCK KGAA

      Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials sectors.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates a diversified portfolio of businesses in life sciences, diagnostics, and environmental solutions.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides laboratory instruments, software, and services for life sciences and diagnostics.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research products and clinical diagnostics equipment.

      ILLUMINA, INC.

      Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company develops and manufactures DNA sequencing and genetic analysis systems.

      TAKARA BIO INC.

      Takara Bio Inc. is a Japan-based private company founded in 2002 with 1,779 employees. The company specializes in biotechnology products and services for research and diagnostics.

      REVVITY INC.

      Revvity Inc. is a United States-based public company founded in 1937 with 11,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

      BIONEER CORPORATION

      Bioneer Corporation is a South Korea-based public company founded in 1992 with 392 employees. The company develops and manufactures molecular biology reagents and diagnostic products.

      Reasons to Buy this Report

      • Italy-Specific Market Sizing : Access precise valuation data for Italy's nucleic acid market ($57.09M in 2026), enabling accurate budget allocation and investment decisions tailored to the Italian healthcare landscape.
      • Competitive Landscape Intelligence : Understand Italy's pharmaceutical and biotech competitive dynamics, identifying key players, market share distribution, and strategic opportunities within the Italian nucleic acid isolation sector.
      • Growth Trajectory Forecasting : Leverage Italy-specific CAGR projections (8.5%) and 2031 forecasts ($85.69M) to develop long-term market strategies and identify optimal entry or expansion timing in the Italian market.
      • Regulatory & Healthcare Insights : Gain insights into Italy's healthcare regulations, clinical laboratory standards, and molecular diagnostics adoption patterns that influence nucleic acid product demand and market development.
      • Targeted Customer Identification : Identify and prioritize Italian research institutions, hospitals, pharmaceutical companies, and diagnostic laboratories driving nucleic acid isolation demand for focused sales and partnership strategies.

      Frequently asked questions

      What is the current market size of nucleic acid isolation and purification in Italy?

      Italy's nucleic acid isolation and purification market is valued at $57.09 million in 2026 and is expected to grow to $85.69 million by 2031.

      What is the projected growth rate for Italy's nucleic acid isolation market?

      Italy's nucleic acid isolation and purification market is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2031.

      What factors are driving growth in Italy's nucleic acid isolation market?

      Growth in Italy is driven by increasing adoption of molecular diagnostics, rising prevalence of genetic and infectious diseases, investments in research infrastructure, and the shift toward personalized medicine and next-generation sequencing.

      Which sectors in Italy are the primary consumers of nucleic acid isolation products?

      Italy's primary consumers include hospitals, diagnostic laboratories, research institutions, pharmaceutical companies, and biotechnology firms engaged in genomic research and clinical diagnostics.

      How does Italy's market compare to the global nucleic acid isolation market?

      Italy's market growth rate of 8.5% is slightly below the global CAGR of 8.7%, reflecting regional variations in healthcare spending, regulatory adoption, and biotechnology investment levels.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global nucleic acid isolation and purification market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global nucleic acid isolation and purification market. The secondary sources used for this study include WHO Disease Statistics (Oncology, Genetic Disorders), CMS Clinical Laboratory Improvement Amendments (CLIA) Laboratory Lists, Association of Public Health Laboratories (APHL) List, Regional Forensic Laboratories list, State Office of Chief Medical Examiner (OCME) List, Biocluster List of Members (Massbio, NC Bio, CLSA), Organization for Economic Co-operation and Development (OECD) R&D Expenditure, National Animal Health Laboratory Network (NAHLN) laboratories List, Genome Canada Membership List, Genome Canada Laboratories Network, Canada Statistics Business Enterprise R&D Statistics, EudraGMP Sites, Biodeutschland Member List, European Federation of Pharmaceutical Industries and Associations (EFPIA) R&D Spending, European Union Drugs Agency (EUDA) Network of forensic and toxicological laboratories list, EudraGMP Sites, BioIndustry Association Member List, NHS Genomics Laboratories Hub, UK Health Security Agency's Laboratories List, FranceBiotech List, China Pharmaceutical Industry Association (CPIA) Member List, China Chinese Center for Disease Control and Prevention (CDC) National Institute for Viral Disease Control and Prevention (IVDC) Laboratories, Japan Pharmaceutical Manufacturers Association (JPMA) & Japanese Bankers Association (JBA) Statistics, NIID (National Institute of Infectious Diseases) reference labs, Indian Pharmaceutical Association (IPA) and Organisation of Pharmaceutical Producers of India (OPPI) Membership List, Brazilian Association of Research-Based Pharmaceutical Industries (Interfarma), Fiocruz Genomic Network Institutes, KAUST Research and Technology Park Companies, Saudi Public Health Authority (Weqaya) National Reference Laboratory System, African Biomedical Engineering Consortium List, Africa CDC Pathogen Genomics Initiative (Africa PGI) Sequencing Laboratories; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      Following an initial assessment of the global nucleic acid isolation and purification market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were conducted with key supply-side participants, including C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% were conducted with demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to comprehensively understand market dynamics.

      Nucleic Acid Isolation and Purification market 
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both bottom-up and top-down approaches were used to estimate and validate the total size of the global nucleic acid isolation and purification market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • A list of the major global players operating in the nucleic acid isolation and purification market was generated.
      • The revenues generated from their nucleic acid isolation and purification product portfolios have been determined through annual reports and secondary sources (including paid databases).
      • The products were mapped according to the segments of the market. Percentage shares and splits were determined based on each segment's revenue contribution. This was verified using secondary sources and by industry experts.
      • All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

      Nucleic Acid Isolation and Purification market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Nucleic acid isolation and purification is a set of molecular biology techniques used for the extraction of DNA and RNA for use in downstream applications, such as sequencing, cloning, and polymerase chain reaction. These downstream applications are important parts of life science research, molecular diagnostics, forensics, and genetic engineering. The report defines the Nucleic acid isolation and purification market as the supplier revenue market for kits, reagents, and instruments used for method, application, type of nucleic acid, and type of samples as described below in the inclusions and exclusions.

      Key Stakeholders

      • OEMs, contract manufacturers, and distributors of nucleic acid isolation and purification kits, reagents, and instruments
      • Start-ups, platform technology & service providers
      • Diagnostic centers, government hospitals, and private clinics
      • Pharmaceutical & biotechnology companies
      • Contract research organizations and other service providers
      • Government institutions & associations funding pharmaceutical & biotechnology R&D
      • Venture capitalists and investors
      • Research associations related to genomics
      • Forensic laboratories
      • Veterinary hospitals/clinics
      • Food testing laboratories

      Report Objectives

      • To define, describe, and forecast the global nucleic acid isolation and purification market based on product, method, type, sample type, application, and end user
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the nucleic acid isolation and purification market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
      • To profile the key players in the global nucleic acid isolation and purification market and comprehensively analyze their product portfolios, market positions, and core competencies
      • To analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the nucleic acid isolation and purification market
      • To benchmark players within the nucleic acid isolation and purification market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company's needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to three).

      Geographical Analysis

      • A further breakdown of the Rest of Asia Pacific nucleic acid isolation and purification market into countries
      • A further breakdown of the Rest of Europe nucleic acid isolation and purification market into countries
      • A further breakdown of the Rest of Latin America nucleic acid isolation and purification market into countries

       

      Get the Full Nucleic Acid Isolation and Purification Market Report

      Full forecast, segment splits, and company analysis for all Nucleic Acid Isolation and Purification Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status